Submit Release

EIN Presswire is celebrating 30 years! Follow us on Substack for customer insights, interviews, and more!

World Media Directory · RSS · Email Newsletters

There were 1,537 press releases posted in the last 24 hours and 429,443 in the last 365 days.

b3c newswire Press Releases

1,798 Press Releases

Published on October 6, 2016 - 13:14 GMT

RedHill Biopharma Provides Progress Update on RHB-104 Phase III Crohn’s Disease Program and Introduces Option for Early Stop for ...

An option for early stop for success for overwhelming efficacy has been introduced into the ongoing first Phase III study with RHB-104 for Crohn’s disease (the “MAP US” study) and analysis is expected in the second quarter of 2017 as part of a second …

Distribution channels: Technology
Published on October 6, 2016 - 13:14 GMT

RedHill Biopharma to Host Webcast Today at 8:30 am EDT Following Announcement of Progress Update on RHB-104 Phase III Crohn’s ...

TEL-AVIV, Israel, October 6, 2016 / B3C newswire / -- RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, …

Distribution channels: Technology
Published on October 6, 2016 - 09:16 GMT

Orchard Therapeutics Announces the Opening of US Operations in Foster City, California

London, UK, October 06, 2016 / B3C newswire / -- Orchard Therapeutics, a UK-based biotechnology company, today announces the opening of its US operations in Foster City, California. Orchard is developing a global platform of ex-vivo autologous gene …

Distribution channels: Technology
Published on October 5, 2016 - 13:51 GMT

RedHill Biopharma Announces Initiation of Phase II Study with YELIVA™ in Hepatocellular Carcinoma at the Medical University of ...

The Phase II clinical study is intended to evaluate the efficacy and safety of YELIVA™ (ABC294640) in patients with advanced hepatocellular carcinoma (HCC), the most common primary malignant cancer of the liver with a worldwide mortality rate of 95% The …

Distribution channels: Technology
Published on October 5, 2016 - 09:01 GMT

Karus Therapeutics Announces First Lymphoma Patients Dosed with KA2237 in Clinical Study at the MD Anderson Cancer Center

First cohort of cancer patients has been dosed with Karus’s lead candidate, KA2237 Potential first-in-class dual-PI3K-p110beta/delta inhibitor with broad potential to treat hematological and solid tumors KA2237 combines an immunotherapeutic response and a …

Distribution channels: Technology
Published on October 5, 2016 - 09:01 GMT

Vector Vitale Announces New Paradigm in Medicine

Sunny Isles Beach, Florida, October 05, 2016 / B3C newswire/ -- Researchers from Vector Vitale Inc., a Florida (USA) based company, have found that maintaining the right isotope ratio of essential chemical elements representing less than one percent of …

Distribution channels: Technology
Published on October 4, 2016 - 08:58 GMT

Argint International Voted as Top10 CRO

Budapest, Hungary, October 04, 2016 / B3C newswire / -- Argint International (“Argint”), a European clinical research organisation specialised in providing services to small and medium sized pharmaceutical and biotech companies, have been ranked as a top …

Distribution channels: Technology
Published on October 4, 2016 - 08:58 GMT

Nuevolution Announces Strategic Collaboration with Amgen in Oncology and Neuroscience

Provides Amgen access to Nuevolution’s proprietary Chemetics® drug discovery platform to identify and develop novel therapeutics Nuevolution is eligible to receive up to USD 410 million per development program and tiered royalties on future sales Amgen has …

Distribution channels: Technology
Published on September 30, 2016 - 13:26 GMT

Sartorius Stedim Biotech Launches Two Single-Use Sartocon® Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane

Assemblies save up to 60 percent on processing time and offer a safe approach to ultrafiltration of biologics and vaccines Goettingen, Germany and Aubagne, France, September 30, 2016 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading …

Distribution channels: Technology
Published on September 30, 2016 - 10:45 GMT

Dutch Mellon Medical Unveils Major Innovation in Surgical Suture Technology: Single-Handed Suturing Using The Switch®

The disposable Switch® technology allows for high precision suturing of tubular (e.g. arteries) and layered structures (e.g. skin), twice as fast as the conventional technique High precision and faster suturing provides benefits to patients as it reduces …

Distribution channels: Technology
Published on September 27, 2016 - 12:23 GMT

Quantapore Inc. Closes Series C Financing Round

Menlo Park, CA, USA, September 27, 2016 / B3C newswire / -- Quantapore Inc. today announced that it has closed a Series C financing round, led by China BioPharma Capital I, a venture capital fund advised by TVM Capital Life Science via its Hong Kong based …

Distribution channels: Technology
Published on September 23, 2016 - 07:49 GMT

Shuwen Biotech's Clinical Lab Receives Accreditation from College of American Pathologists

Deqing, China, September 23, 2016 / B3C newswire / -- Shuwen Biotech Co. Ltd., a China-based diagnostic company focused on licensing, developing and commercializing diagnostic kits and services for unmet clinical needs, has announced today that the …

Distribution channels: Technology
Published on September 22, 2016 - 16:48 GMT

Nuevolution: Oral Presentation of Preclinical and Preliminary Toxicology Data on its BET BD1 Program at Discovery on Target 2016

Stockholm, Sweden, September 22, 2016 / B3C newswire / -- Nuevolution AB (publ) (NUE.ST) will today present preclinical and preliminary toxicology data from its BET BD1 program at Discovery on Target 2016 (DoT 2016) in Boston, MA, USA. Jimmi G. Seitzberg, …

Distribution channels: Technology
Published on September 21, 2016 - 14:55 GMT

Orchard Therapeutics Announces Presentations from UCL/GOSH and UCLA Academic Collaborators on Clinical Data in ADA-SCID Using Ex-...

London, UK, September 21, 2016 / B3C newswire / -- Orchard Therapeutics announces that some of its academic collaborators will be presenting an update from ongoing clinical studies with autologous CD34+ haematopoietic stem cells transduced ex vivo with EFS …

Distribution channels: Technology
Published on September 21, 2016 - 13:58 GMT

FierceBiotech Names Orchard Therapeutics Limited as One of Its “Fierce 15” Biotech Companies of 2016

London, UK, September 21, 2016 / B3C newswire / -- Orchard Therapeutics Limited is proud to report that it has been named by FierceBiotech as one of 2016’s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology …

Distribution channels: Technology
Published on September 21, 2016 - 12:38 GMT

RedHill Biopharma and IntelGenx Announce RIZAPORT® Commercialization Term Sheet with Pharmatronic Co. for Korea

RIZAPORT® (5 mg and 10 mg) was granted marketing approval in Germany under the European Decentralized Procedure (DCP) This binding term sheet for the license of RIZAPORT® in South Korea follows a recent commercialization agreement for Spain with Grupo …

Distribution channels: Technology
Published on September 19, 2016 - 13:28 GMT

TVM Life Science Ventures VII Announces Investment in AurKa Pharma Inc.

Montréal, Québec, Canada, September 19, 2016 / B3C newswire / -- TVM Life Science Ventures VII today announced the fund’s twelfth investment establishing AurKa Pharma Inc., a company based in Montréal, Québec. AurKa Pharma Inc. plans to develop, to proof- …

Distribution channels: Technology
Published on September 19, 2016 - 12:22 GMT

osteomiR™: Worldwide First miRNA-based Test for Early Detection of Osteoporosis

Vienna, Austria / Atlanta, USA, September 19, 2016 / B3C newswire / -- The Austrian spin-off TAmiRNA develops biomarker solutions, which significantly improve early detection of serious age-related illnesses such as osteoporosis. At this years ASBMR …

Distribution channels: Technology
Published on September 16, 2016 - 13:26 GMT

Nuevolution: Presentation of Preclinical Data on its BET BD1 Program at Discovery on Target 2016

Stockholm, Sweden, September 16, 2016 / B3C newswire / -- Nuevolution AB (publ) (NUE.ST) will present preclinical data from its BET BD1 program at Discovery on Target 2016 (DoT 2016) in Boston, MA, USA, on 20 and 22 September. The oral presentation by …

Distribution channels: Technology
Published on September 15, 2016 - 15:14 GMT

Sartorius Stedim Biotech Presents Sartocon® Slice 50 ECO

New small-scale crossflow device for low-viscosity water-based protein solutions Goettingen, Germany, Aubagne, France, September 15, 2016 / B3C newswire / -- Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical …

Distribution channels: Technology

Previous 31 32 33 34 35 36 37 38 39 40 41 Next